similarly, Mounjaro and Zepbound both have the same active ingredient with different indications.) In the STEP 1 trial, people taking semaglutide (Wegovy) at 2.4 mg weekly lost about 15% of their body weight over 68 weeks, compared to roughly 23% in the placebo group
The difference isn't magic
Because of that, stomach-related side effects tend to occur, particularly in the first few weeks
Our Body Contouring page highlights additional treatments that can complement semaglutide therapy by refining results once significant weight loss is achieved
Sem a L-Carnitina, as gorduras no podem ser queimadas para produzir energia e, em vez disso, so desviadas para gordura corporal armazenada
Technique: Inject into the abdomen, thigh, or upper arm